Latest Administration News

BOD Science has executed an asset sale deed transferring critical intellectual property rights to Optimus Salvus, marking a pivotal step in its Deed of Company Arrangement process.

Clarity Pharmaceuticals has secured a second FDA Fast Track Designation for its 64Cu-SAR-bisPSMA diagnostic agent, aiming to revolutionize prostate cancer imaging and speed regulatory approval.

Noble Helium has selected three initial drill sites in its North Rukwa Project in Tanzania, backed by significant helium detections and a flexible funding package including convertible notes and an equity facility. However, drilling has been deferred due to seasonal rains.

Respiri Limited reports a standout December quarter marked by a 67% surge in patient program enrolments and robust revenue growth, bolstered by strategic acquisition synergies from Orb Health. The company is poised for further expansion in 2025 amid promising contract negotiations and evolving US healthcare reimbursement policies.

Conrad Asia Energy reports solid progress in Q4 2024 with finalized gas sales agreements and promising LNG studies, despite delayed final investment decisions due to regulatory approvals.

FAR Limited reports robust production from Senegal’s Sangomar field and a solid cash position, while anticipating a contingent payment from Woodside Energy that could reach US$55 million.

Raptis Group Limited reported a positive net cash inflow from operating activities of $54,509 for the quarter ended December 31, 2024, ending with $303,102 in cash and equivalents. The company recorded no investing or financing cash flows during the period.

CAQ Holdings Limited reported an 8% decrease in leasing revenue for the December 2024 quarter, as tenant negotiations continue amid uncertain government policies affecting the Hainan free trade port development.

Bioxyne Limited has raised its FY2025 revenue forecast to $25 million, driven by a remarkable 267% increase in first-half revenue and strong momentum from its subsidiary Breathe Life Sciences.

Regional Express Holdings has completed the transfer of debt from PAGAC Regulus Holding to the Commonwealth of Australia, marking a key step in its ongoing administration process.

InhalerX Limited reported a negative cash flow for the December quarter despite securing a substantial $38.5 million funding facility aimed at advancing its clinical trials. The company has yet to draw on this facility, maintaining a cautious cash position as it progresses its drug development programs.

Regional Express Holdings has assigned a $50 million portion of its debt to the Commonwealth of Australia, making the government the largest secured creditor as the airline navigates voluntary administration.